Historical record - last NADAC publication: 2/17/2021
Product Information
SAVAYSA 30 MG TABLET is a brand product labeled by Daiichi Sankyo Inc., priced at $12.4819 per EA under NDC 65597020205. Its NADAC has been published 327 times since Oct 21, 2015.
Strength
30 mg/1
Manufacturer
Daiichi Sankyo Inc.NDC
65597020205
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
2/17/2021
Active Ingredients
EDOXABAN TOSYLATEApproval Type
New Drug (NDA)
FDA Application
NDA206316On Market Since
1/12/2015
Pharmacological Classes
Price Statistics
The NADAC for SAVAYSA 30 MG TABLET has been published 327 times since Oct 21, 2015, and over the history we have for it it has risen 37.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $12.4819 per EA |
|---|---|
| All-time high | $12.4819 (Feb 16, 2022) |
| All-time low | $9.0683 (Oct 21, 2015) |
| Median price | $10.8083 |
| Average price | $11.0956 |
| Largest weekly change | +8.0% (Jan 16, 2019) |
| Weeks tracked | 327 |
| Tracking since | Oct 21, 2015 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SAVAYSA 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SAVAYSA 30 MG TABLET, manufactured by Daiichi Sankyo Inc., is $12.4819 per EA (NDC 65597020205), effective Feb 16, 2022.
How has the price of SAVAYSA 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for SAVAYSA 30 MG TABLET has risen 37.6%. It has been tracked across 327 weekly CMS publications since Oct 21, 2015.
What are the highest and lowest recorded NADAC prices for SAVAYSA 30 MG TABLET?
Since Oct 21, 2015, the NADAC for SAVAYSA 30 MG TABLET has ranged from a low of $9.0683 (Oct 21, 2015) to a high of $12.4819 (Feb 16, 2022), with a median of $10.8083 per EA.
Are there cheaper alternatives to SAVAYSA 30 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as SAVAYSA 30 MG TABLET, but none are currently priced below it.
Who manufactures SAVAYSA 30 MG TABLET?
SAVAYSA 30 MG TABLET (NDC 65597020205) is labeled by Daiichi Sankyo Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification